Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

ACC/AHA Update Performance, Quality Measures for HF Care

News Daily News

ACC/AHA Update Performance, Quality Measures for HF Care

August 08, 2024

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

News Daily News

First-Ever Performance, Quality Metrics Created for Valvular and Structural Disease

Michael O'Riordan

March 20, 2024

Surgery and ‘Care-Bundle’ Trials Raise Hopes for ICH Care

News Conference News ESOC 2023

Surgery and ‘Care-Bundle’ Trials Raise Hopes for ICH Care

May 26, 2023

BETTER CARE-HF: Embedded EHR Alert Boosts MRA Prescribing in HFrEF

News Conference News ACC 2023

BETTER CARE-HF: Embedded EHR Alert Boosts MRA Prescribing in HFrEF

March 06, 2023

As TAVI Turns 20, How Has the Heart Team Evolved?

News Features

As TAVI Turns 20, How Has the Heart Team Evolved?

Yael L. Maxwell

May 04, 2022

DIAMOND Shines Bright on Patiromer for Curbing Hyperkalemia in HFrEF

News Conference News ACC 2022

DIAMOND Shines Bright on Patiromer for Curbing Hyperkalemia in HFrEF

April 08, 2022

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

AI in Cardiology: Where We Are Now and Where to Go Next

News Features

AI in Cardiology: Where We Are Now and Where to Go Next

Yael L. Maxwell

March 30, 2021

CMS Extends MitraClip Coverage to Functional MR, Carves Out Imager Role

News Daily News

CMS Extends MitraClip Coverage to Functional MR, Carves Out Imager Role

January 20, 2021

Endovascular Stroke Therapy Less Beneficial After Transfer

News Daily News

Endovascular Stroke Therapy Less Beneficial After Transfer

August 27, 2020

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

News Daily News

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Michael O'Riordan

July 17, 2019

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

March 10, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.